DIRECTORS ELECTED AT ANNUAL GENERAL MEETING
10 Septiembre 2010 - 1:47PM
PR Newswire (Canada)
VANCOUVER, Sept. 10 /CNW/ -- VANCOUVER, Sept. 10 /CNW/ - Burcon
NutraScience Corporation (TSX - BU) ("Burcon" or the "Corporation")
announced today that eight incumbent directors were re-elected to
its Board at its annual meeting of shareholders held on September
9, 2010. The directors re-elected are: Dr. Allan Yap, Mr. Johann F.
Tergesen, Ms. Rosanna Chau, Mr. Paul Westdal, Mr. Richard O'C.
Whittall, Dr. Lawrence Wang, Dr. David Lorne John Tyrrell and Mr.
Alan Chan. Burcon would also like to take this opportunity to thank
Mr. Stuart MacGregor for his contribution as a board member of
Burcon from June 2002 to September 2010. During the past
eight years, Mr. MacGregor has made significant contributions to
Burcon. Mr. MacGregor, president of MacGregor Equities Inc., a
private investment management partnership with a focus on private
equity investments, brought a wealth of knowledge to Burcon's board
from his over 30 years of investment banking and financial
management experience. During his tenure on Burcon's board,
Mr. MacGregor served on and chaired numerous committees including
the audit committee, the nominating and compensation committee and
the corporate governance committee of the board of directors.
Dr. Allan Yap, chairman of Burcon's board of directors, said,
"Burcon is fortunate to have a board consisting of highly skilled
and experienced individuals who bring a wealth of expertise to the
Corporation. Over the past eight years, Mr. MacGregor
has been a great asset and contributed to Burcon's growth and
development. Burcon would like to thank him for his
commitment and support and acknowledge all his hard work and
efforts. We wish him success in all his future projects."
About Burcon NutraScience Burcon is a leader in nutrition, health
and wellness in the field of functional, renewable plant proteins.
Since 1999, Burcon has developed a portfolio of composition,
application, and process patents originating from our core protein
extraction and purification technology. We are developing Puratein®
and Supertein™ canola protein isolates with unique functional and
nutritional attributes, and CLARISOY(®), a revolutionary soy
protein isolate which is 100% soluble and completely transparent in
acidic solutions. Our team of highly specialized scientists and
engineers work from our own research facility to develop and
optimize environmentally sound technologies. To-date, our patent
portfolio consists of 136 issued patents in various countries,
including 20 issued U.S. patents, and in excess of 200 additional
pending patent applications, 66 of which are U.S. patent
applications. ON BEHALF OF THE BOARD OF DIRECTORS"Johann F.
Tergesen"Johann F. TergesenPresident and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This
press release contains forward-looking statements that involve
risks and uncertainties. These forward-looking statements relate
to, among other things, plans and timing for the introduction or
enhancement of our products, statements about future market
conditions, supply and demand conditions, and other expectations,
intentions and plans contained in this press release that are not
historical fact. Our expectations regarding the prospect for future
success depend upon our ability to develop and sell products, which
we do not produce today and cannot be sold without further research
and development. When used in this press release, the words "goal",
"intend", "believes" and "potential" and similar expressions,
generally identify forward-looking statements. These statements
reflect our current expectations. They are subject to a number of
risks and uncertainties. In light of the many risks and
uncertainties surrounding the development of a source of protein
from canola meal, you should understand that we cannot assure you
that the forward looking statements contained in this press release
will be realized. p align="center"Jade Cheng, Chief Financial
Officerbr/Burcon NutraScience Corporationbr/(604) 733-0896 / (888)
408-7960 toll-freebr/a
href="mailto:jcheng@burcon.ca"jcheng@burcon.ca/a a
href="www.burcon.ca"www.burcon.ca/a/p p align="center"bAXINO
AGbr//bWolfgang Seybold, Investor Relations Europebr/AXINO AG,
Königstraße 26, 70173 Stuttgart, Germanybr/Tel. +49-711-25 35 92-40
/ Fax +49-711-25 35 92-55br/a
href="mailto:wolfgang.seybold@axino.de"wolfgang.seybold@axino.de/a
a href="www.burcon.net"www.burcon.net/a/p
Copyright
Burcon NutraScience (TSX:BU)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Burcon NutraScience (TSX:BU)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Burcon NutraScience Corporation (Toronto Stock Exchange): 0 recent articles
Más de Burcon Nutrascience Corp. Artículos de Noticias